A study on the epidemiology of rosacea in the U.K.

British Journal of Dermatology

Volumn 167, Issue 3, 2012, Pages 598-605

  Spoendlin, J ^a,b   Voegel, J J ^c   Jick, S S ^d   Meier, C R ^a,b,d  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c Galderma R and D   (France)

^d BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLEPHARITIS; BLURRED VISION; CLINICAL PRACTICE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONJUNCTIVITIS; CONTROLLED STUDY; CORNEA DISEASE; DATA BASE; DEMOGRAPHY; DRY EYE; EPIDEMIOLOGICAL DATA; EPIPHORA; EYE DISEASE; EYE INFLAMMATION; EYE IRRITATION; EYE PAIN; EYE REDNESS; FEMALE; HIGH RISK PATIENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OCULAR PRURITUS; PREVALENCE; PRIORITY JOURNAL; RISK; ROSACEA; SEX DIFFERENCE; SMOKING; UNITED KINGDOM;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; EPIDEMIOLOGIC METHODS; FEMALE; GREAT BRITAIN; HUMANS; INCIDENCE; INFANT; LIFE STYLE; MALE; MIDDLE AGED; ROSACEA; SMOKING; YOUNG ADULT;

EID: 84865600855     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2012.11037.x     Document Type: Article

References (50)

1. Crawford GH, Pelle MT, James WD,. Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol 2004; 51: 327-41. (Pubitemid 39178655)
2. van Zuuren EJ, Kramer S, Carter B, et al. Interventions for rosacea. Cochrane Database Syst Rev 2011; 3: CD003262.
3. Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol 2002; 46: 584-7.
4. Oltz M, Check J,. Rosacea and its ocular manifestations. Optometry 2011; 82: 92-103.
5. Langenbruch AK, Beket E, Augustin M,. Quality of health care of rosacea in Germany from the patient's perspective: results of the National Health Care Study RosaReal 2009. Dermatology 2011; 223: 124-30.
6. Aksoy B, Altaykan-Hapa A, Egemen D, et al. The impact of rosacea on quality of life: effects of demographic and clinical characteristics and various treatment modalities. Br J Dermatol 2011; 163: 719-25.
7. Powell FC,. Clinical practice. Rosacea. N Engl J Med 2005; 352: 793-803.
8. Katz AM,. Rosacea: epidemiology and pathogenesis. J Cutan Med Surg 1998; 2 (Suppl. 4): 5-10.
9. Bae YI, Yun SJ, Lee JB, et al. Clinical evaluation of 168 Korean patients with rosacea: the sun exposure correlates with the erythematotelangiectatic subtype. Ann Dermatol 2009; 21: 243-9.
10. Jansen T, Plewig G,. Rosacea: classification and treatment. J R Soc Med 1997; 90: 144-50. (Pubitemid 27135946)
11. Berg M, Liden S,. An epidemiological study of rosacea. Acta Derm Venereol (Stockh) 1989; 69: 419-23. (Pubitemid 19226109)
12. Blount BW, Pelletier AL,. Rosacea: a common, yet commonly overlooked, condition. Am Fam Physician 2002; 66: 435-40.
13. Yamasaki K, Gallo RL,. The molecular pathology of rosacea. J Dermatol Sci 2009; 55: 77-81.
14. Abram K, Silm H, Maaroos HI, et al. Risk factors associated with rosacea. J Eur Acad Dermatol Venereol 2010; 24: 565-71.
15. Steinhoff M, Buddenkotte J, Aubert J, et al. Clinical, cellular, and molecular aspects in the pathophysiology of rosacea. J Investig Dermatol Symp Proc 2011; 15: 2-11.
16. Schwab VD, Sulk M, Seeliger S, et al. Neurovascular and neuroimmune aspects in the pathophysiology of rosacea. J Investig Dermatol Symp Proc 2011; 15: 53-62.
17. Bamford JT, Gessert CE, Renier CM, et al. Childhood stye and adult rosacea. J Am Acad Dermatol 2006; 55: 951-5. (Pubitemid 44716470)
18. Kyriakis KP, Palamaras I, Terzoudi S, et al. Epidemiologic aspects of rosacea. J Am Acad Dermatol 2005; 53: 918-19.
19. Augustin M, Herberger K, Hintzen S, et al. Prevalence of skin lesions and need for treatment in a cohort of 90 880 workers. Br J Dermatol 2011; 165: 865-73.
20. Schaefer I, Rustenbach SJ, Zimmer L, et al. Prevalence of skin diseases in a cohort of 48,665 employees in Germany. Dermatology 2008; 217: 169-72.
21. Doe PT, Asiedu A, Acheampong JW, et al. Skin diseases in Ghana and the UK. Int J Dermatol 2001; 40: 323-6. (Pubitemid 32851107)
22. Lomholt G,. Prevalence of skin diseases in a population; a census study from the Faroe Islands. Dan Med Bull 1964; 11: 1-7.
23. McAleer MA, Fitzpatrick P, Powell FC,. Papulopustular rosacea: prevalence and relationship to photodamage. J Am Acad Dermatol 2010; 63: 33-9.
24. Abram K, Silm H, Oona M,. Prevalence of rosacea in an Estonian working population using a standard classification. Acta Derm Venereol (Stockh) 2010; 90: 269-73.
25. Wilkin JK,. Rosacea. Int J Dermatol 1983; 22: 393-400. (Pubitemid 13001558)
26. Culp B, Scheinfeld N,. Rosacea: a review. Pharm Ther 2009; 34: 38-45.
27. Lazaridou E, Fotiadou C, Ziakas N, et al. Clinical and laboratory study of ocular rosacea in northern Greece. J Eur Acad Dermatol Venereol 2011; 25: 1428-31.
28. Michel JL, Cabibel F,. Frequency, severity and treatment of ocular rosacea during cutaneous rosacea. Ann Dermatol Venereol 2003; 130: 20-4. (Pubitemid 36287923)
29. Starr PA, Macdonald A,. Oculocutaneous aspects of rosacea. Proc R Soc Med 1969; 62: 9-11.
30. Ghanem VC, Mehra N, Wong S, et al. The prevalence of ocular signs in acne rosacea: comparing patients from ophthalmology and dermatology clinics. Cornea 2003; 22: 230-3. (Pubitemid 36359159)
31. Browning DJ, Proia AD,. Ocular rosacea. Surv Ophthalmol 1986; 31: 145-58. (Pubitemid 17222026)
32. Bakar O, Demircay Z, Toker E, et al. Ocular signs, symptoms and tear function tests of papulopustular rosacea patients receiving azithromycin. J Eur Acad Dermatol Venereol 2009; 23: 544-9.
33. Mills CM, Marks R,. Environmental factors influencing rosacea. Clin Exp Dermatol 1996; 21: 172-3.
34. Breton AL, Truchetet F, Veran Y, et al. Prevalence analysis of smoking in rosacea. J Eur Acad Dermatol Venereol 2010; 25: 1112-13.
35. Curnier A, Choudhary S,. Rhinophyma: dispelling the myths. Plast Reconstr Surg 2004; 114: 351-4. (Pubitemid 39201634)
36. Gupta MA, Gupta AK, Chen SJ, Johnson AM,. Comorbidity of rosacea and depression: an analysis of the National Ambulatory Medical Care Survey and National Hospital Ambulatory Care Survey-Outpatient Department data collected by the U.S. National Center for Health Statistics from 1995 to 2002. Br J Dermatol 2005; 153: 1176-81. (Pubitemid 41779573)
37. Sobye P,. Aetiology and pathogenesis of rosacea. Acta Derm Venereol (Stockh) 1950; 30: 137-58.
38. Khan NF, Harrison SE, Rose PW,. Validity of diagnostic coding within the General Practice Research Database: a systematic review. Br J Gen Pract 2010; 60: e128-36.
39. Jick SS, Kaye JA, Vasilakis-Scaramozza C, et al. Validity of the General Practice Research Database. Pharmacotherapy 2003; 23: 686-9. (Pubitemid 36539051)
40. Wood L, Martinez C,. The General Practice Research Database: role in pharmacovigilance. Drug Saf 2004; 27: 871-81. (Pubitemid 39331685)
41. Gibson GE, Codd MB, Murphy GM,. Skin type distribution and skin disease in Ireland. Ir J Med Sci 1997; 166: 72-4. (Pubitemid 27216278)
42. Sopori M,. Effects of cigarette smoke on the immune system. Nat Rev Immunol 2002; 2: 372-7. (Pubitemid 37328760)
43. Abraham N, Selby W, Lazarus R, et al. Is smoking an indirect risk factor for the development of ulcerative colitis? an age- and sex-matched case-control study. J Gastroenterol Hepatol 2003; 18: 139-46. (Pubitemid 36349858)
44. Edvinsson ML, Andersson SE, Xu CB, et al. Cigarette smoking leads to reduced relaxant responses of the cutaneous microcirculation. Vasc Health Risk Manag 2008; 4: 699-704. (Pubitemid 352037928)
45. Lewis JD, Brensinger C,. Agreement between GPRD smoking data: a survey of general practitioners and a population-based survey. Pharmacoepidemiol Drug Saf 2004; 13: 437-41. (Pubitemid 38996854)
46. Borrie P,. Rosacea with special reference to its ocular manifestations. Br J Dermatol 1953; 65: 458-63.
47. Chamaillard M, Mortemousque B, Boralevi F, et al. Cutaneous and ocular signs of childhood rosacea. Arch Dermatol 2008; 144: 167-71. (Pubitemid 351286999)
48. Gupta AK, Bluhm R, Cooper EA, et al. Seborrheic dermatitis. Dermatol Clin 2003; 21: 401-12. (Pubitemid 37022666)
49. Burton JL, Pye RJ, Meyrick G, et al. The sebum excretion rate in rosacea. Br J Dermatol 1975; 92: 541-3.
50. Holme SA, Scott-Lang VE, Ooi ET, et al. The South-East Scotland Dermatology Workload Study: 30 years' analysis. Br J Dermatol 2012; 167: 123-30.